Few companies can legitimately claim to have made a profound impact on human history. Moderna (NASDAQ: MRNA) is arguably an exception. The biotech's rapid development of a highly effective COVID-19 vaccine could help bring an end to the global pandemic.
It's no surprise that Moderna has been a big winner for investors, with its shares skyrocketing nearly 800% since the beginning of 2020. But is Moderna stock a buy now after this huge gain?
Image source: Getty Images.
Source Fool.com